Innovative Solutions and Better Products for Women with Saundra Pelletier of Evofem

26 Apr 2022 · 39 min
Open on Podcast

Transcript of a Tacos and Tech podcast interview (host Neil Bloom) with Saundra Pelletier, CEO of Evofem Biosciences. Pelletier describes Evofem's hormone-free, on-demand vaginal contraceptive (Fexi), its mechanism (acid-buffering to maintain vaginal pH), product format (prescription box of 12 prefilled 5 mL applicators), clinical and commercial plans (phase‑3 STI prevention enrollment completed; topline data expected in Q4), company history and founding, fundraising/challenges during COVID, DTC marketing choices, company culture, and Pelletier's career and advocacy in women's health.

Questions this episode answers

A prescription is a box of 12 prefilled applicators; each applicator contains 5 mL.

Normal vaginal pH is stated as 3.5 to 4.5.

Semen raises vaginal pH to approximately 7 or 8.

Lactic acid, citric acid, and potassium bitartrate.

23 million women in the US are described as beyond hormones.

More from Neal

1:05:20
Podcast

Every Driving School Said No

1w ago
58:22
Podcast

Thirst Is a Lagging Indicator

3w ago
1:14:01
Podcast

Measure It at the Source

1mo ago
29:51
Podcast

A Different Person in Every Game

1mo ago
42:00
Podcast

Teams Don’t Exist in Business

1mo ago
42:15
Podcast

Food for the People

2mo ago
49:44
Podcast

Signals Before Symptoms

2mo ago
48:04
Podcast

The Connective Tissue

2mo ago
28:44
Podcast

Beyond the Blueprint

2mo ago
1:08:04
Podcast

Why Great Companies Go Bad

3mo ago
41:24
Podcast

Diversification Is Overrated

3mo ago
See all content